US$ 21.53
glp-1 drugs come from the Gray Market GLP-1 Drug Savings: A Complete
Description
This exorbitant cost makes GLP-1RAs inaccessible to most, and it likely wont be changing soon

[DOI] [PubMed] [Google Scholar] 369.Orskov C., Nielsen J.H

Then to 0.25 mg every other week for four weeks

Differences: Duration of Action: Short-acting GLP-1RAs (e.g., exenatide twice daily or lixisenatide) act by primarily delaying gastric emptying
Against this backdrop, competitive intensity is expected to escalate, but high capital requirements and manufacturing know-how should keep the market from fragmenting rapidly
